Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I)
2 clinical trials · Condition
◉ Watch Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I)
| Record | Firm | Date |
|---|---|---|
| Open-Label Extension Study of BBP-418 (Ribitol) for LGMD2I/R9 (NCT07678775) | ML Bio Solutions, Inc. | 2026-06-05 |
| Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I) (NCT05775848) | ML Bio Solutions, Inc. | 2023-05-31 |
Track Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I) automatically
Every clearance here is in the API, with alerts when new ones post.